Send the following on WhatsApp
Continue to Chat羅氏雙特異性抗體 Faricimab 緩解眼中風達成主要療效指標 https://geneonline.news/roche-faricimab-rvo-primary-endpoint/?variant=zh-cn
羅氏雙特異性抗體 Faricimab 緩解眼中風達成主要療效指標 https://geneonline.news/roche-faricimab-rvo-primary-endpoint/?variant=zh-cn